• Electric Bandage May Spur Healing
    At the time of his death, Christopher Reeve was being treated for a systemic infection caused by a pressure ulcer. About 30 percent of people with spinal cord injuries suffer from pressure wounds each year. Researchers at the University of Alabama at Birmingham (UAB) School ...More
    October 18, 2004 Posted in News
  • The Long Road to a Promising Malaria Vaccine Started at NYU
    The malaria vaccine reported today to reduce life-threatening cases of the parasitic disease among children in Mozambique is based on the pioneering research of Drs. Ruth and Victor Nussenzweig and their colleagues at NYU School of Medicine. Ruth Nussenzweig, Doc en Med, ...More
    October 18, 2004 Posted in News
  • Researchers Confirm Cranberries Can Treat Herpes
    Alpine cranberries have significant biological activity that can help to combat herpes virus type II (HSV-2) infection, one of the most common viral infections in humans, writes Emma Dorey in Chemistry & Industry. Researchers at the Kaohsiung Medical University in ...More
    October 18, 2004 Posted in News
  • Promising Results for Malaria Vaccine Trial
    Encouraging phase II results of a trial to test the efficacy of a malaria vaccine for young children is published in this week’s issue of The Lancet. Over 1 million people a year die from malaria, many of them being young children. The emergence of resistance to previously ...More
    October 14, 2004 Posted in News
  • Flu Shot and Nasal Spray Flu Vaccine Tested Side by Side
    A University of Michigan influenza expert is beginning a three-year direct comparison of the effectiveness of flu shots versus nasal spray flu vaccine. Flu shots have been around since World War II, and the Centers for Disease Control and Prevention (CDC) has long ...More
    October 14, 2004 Posted in News
  • MedImmune Progressing with Development of Vaccine Targeting Respiratory Syncytial Virus and Parainfluenza Virus Type-3
    GAITHERSBURG, Md. -- MedImmune, Inc. announced today that data from a preclinical study for its lead vaccine candidate to prevent respiratory syncytial virus (RSV) and parainfluenza virus type-3 (PIV-3) has shown a protective immune response against both viruses in animals. ...More
    October 14, 2004 Posted in News
  • Vanguard Medical Concepts CEO Appoints New Member to Clinical Team
    LAKELAND, Fla. -- Charles A. Masek, chief executive officer of Vanguard Medical Concepts Inc., announced the appointment of Nancy Hesselbach to Vanguard's Clinical Nurse Implementation Team.  In her role as a clinical implementation specialist, Hesselbach will be ...More
    October 14, 2004 Posted in News
  • Influenza Vaccine Supply Update
    Briefing on the Flu SeasonDr. Gerberding with Damian Braga, President,Aventis Pasteur U.S. Tuesday, October 12, 2004- - -DR. GERBERDING: "This has been a very challenging week for all of us and we appreciate that those people who've been worried about flu, those people who ...More
    October 13, 2004 Posted in News
  • Researchers Identify Key Plant Enzyme That Defends Against Multiple Infections
    RIVERSIDE, Calif. – Scientists from the University of California, Riverside have identified one of the key enzymes that trigger programmed cell death, an important process plants undergo in fighting off bacterial, fungal or viral infections. The development holds out hope ...More
    October 13, 2004 Posted in News
  • Five Simple Measures Could Significantly Reduce Global Incidence of Foodborne Disease
    BANGKOK, THAILAND -- Each year, unsafe food makes at least two billion people ill worldwide, or about one third of the global population. Simple prevention techniques could significantly reduce this burden of disease, which can cause serious illness or death. The World ...More
    October 13, 2004 Posted in News